INSP
Inspire Medical Systems, Inc.
$43.84
-0.90
(-2.01%)
Mkt Cap
1.26B
Volume
1,229,675
52W Range
39.61-147.66
Sector
Healthcare
Beta
0.83
EPS (TTM)
4.53
P/E Ratio
9.68
Revenue (TTM)
915.25M
Rev Growth (5Y)
+51.2%
EPS Growth (5Y)
N/A
AlphaVal · Fair Value
$71.12
Undervalued · Moderate
38.4% below fair value
AlphaQuality · Grade · Gated
F
Platform & Compounding FCF
30.0 / 100 pillar composite (overridden)
Company Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 911.98M | 802.80M | 624.80M | 407.86M | 233.39M | 115.38M | 82.05M | 50.59M | 28.57M | 16.43M | 8.01M |
| Net Income | 145.42M | 53.51M | (21.15M) | (44.88M) | (42.04M) | (57.20M) | (33.24M) | (21.83M) | (17.51M) | (18.53M) | (21.34M) |
| EPS | 4.95 | 1.80 | -0.72 | -1.60 | -1.54 | -2.19 | -1.40 | -1.50 | -1.30 | -1.49 | -1.71 |
| Free Cash Flow | 78.48M | 91.12M | 1.02M | 2.47M | (24.79M) | (55.50M) | (35.59M) | (18.94M) | (16.20M) | (18.25M) | N/A |
| FCF / Share | 2.67 | 3.06 | 0.03 | 0.09 | -0.91 | -2.13 | -1.49 | -1.30 | -1.20 | -1.46 | N/A |
| Operating CF | 116.98M | 130.25M | 24.65M | 11.57M | (20.12M) | (53.05M) | (32.85M) | (18.69M) | (15.79M) | (17.95M) | N/A |
| Total Assets | 907.32M | 808.38M | 676.81M | 564.88M | 295.08M | 281.19M | 181.25M | 200.08M | 25.09M | 13.12M | N/A |
| Total Debt | 32.16M | 31.79M | 24.85M | 16.41M | 34.09M | 30.63M | 25.35M | 24.93M | 16.46M | 15.69M | N/A |
| Cash & Equiv | 104.81M | 150.15M | 185.54M | 441.59M | 214.47M | 190.52M | 22.86M | 97.29M | 8.96M | 6.68M | N/A |
| Book Value | 781.16M | 689.70M | 572.51M | 496.01M | 229.05M | 229.75M | 139.84M | 164.00M | 1.48M | (6.61M) | N/A |
| Return on Equity | 0.19 | 0.08 | -0.04 | -0.09 | -0.18 | -0.25 | -0.24 | -0.13 | -11.80 | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 204.58M | 269.08M | 224.50M | 217.09M | 201.32M | 239.72M | 203.19M | 195.88M | 164.01M | 192.51M | 153.30M | 151.09M |
| Net Income | (11.29M) | 136.09M | 9.93M | (3.59M) | 2.99M | 35.22M | 18.50M | 9.79M | (10.01M) | 14.76M | (8.54M) | (11.95M) |
| EPS | -0.39 | 4.70 | 0.34 | -0.12 | 0.10 | 1.18 | 0.62 | 0.33 | -0.34 | 0.50 | -0.29 | -0.41 |
| Free Cash Flow | 3.12M | 41.81M | 58.09M | (6.31M) | (15.11M) | 62.15M | 44.28M | (12.47M) | (2.84M) | 9.23M | (3.35M) | 237,000 |
| FCF / Share | 0.11 | 1.44 | 1.98 | -0.21 | -0.51 | 2.08 | 1.48 | -0.42 | -0.10 | 0.31 | -0.11 | 0.01 |
| Operating CF | 12.85M | 52.47M | 68.53M | 2.68M | (6.70M) | 69.18M | 52.28M | (78,000) | 8.86M | 17.27M | 3.64M | 5.09M |
| Total Assets | 911.38M | 918.49M | 807.72M | 802.19M | 730.81M | 808.38M | 796.19M | 728.39M | 685.84M | 676.81M | 639.49M | 618.25M |
| Total Debt | 29.55M | 62.15M | 32.58M | 33.06M | 33.52M | 31.79M | 25.33M | 24.51M | 24.50M | 24.85M | 25.17M | 23.37M |
| Cash & Equiv | 98.93M | 104.81M | 112.84M | 106.93M | 53.88M | 150.15M | 147.51M | 188.03M | 175.42M | 185.54M | 329.90M | 467.05M |
| Book Value | 792.34M | 781.16M | 666.46M | 677.81M | 635.74M | 689.70M | 696.56M | 638.07M | 589.02M | 572.51M | 544.18M | 529.36M |
| Return on Equity | -0.01 | 0.17 | 0.01 | -0.01 | 0.00 | 0.05 | 0.03 | 0.02 | -0.02 | 0.03 | -0.02 | -0.02 |
INSP News
Inspire Medical Systems, Inc. (INSP) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Inspire: Why I'm Still Rating The Stock A 'Sell' After The Earnings Dip
Inspire Medical Q1 Earnings Beat Estimates, 2026 View Cut, Stock Down
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Applied Materials, Devon Energy, GoDaddy, Home Depot, Lam Research, Lowe’s, Roblox, Tractor Supply, Ulta Beauty, and More
Inspire Medical Systems, Inc. (INSP) Q1 2026 Earnings Call Transcript
Inspire (INSP) Reports Q1 Earnings: What Key Metrics Have to Say
Inspire Medical Systems (INSP) Q1 Earnings and Revenues Top Estimates
Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance
Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference
Tempus AI (TEM) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release